Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica S Klaassen

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|December 30, 2022
Impact of oral administration of single strain <i>Lactococcus lactis</i> spp. <i>cremoris</i> on immune responses to keyhole limpet hemocyanin immunization and gut microbiota: A randomized placebo-controlled trial in healthy volunteersMahdi Saghari, Pim Gal, Hendrika W Grievink, et al.
European Journal of Pain (London, England)|January 1, 2019
The ultraviolet B inflammation model: Postinflammatory hyperpigmentation and validation of a reduced UVB exposure paradigm for inducing hyperalgesia in healthy subjectsPieter S Siebenga, Guido van Amerongen, Erica S Klaassen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
First in human study with a prodrug of galantamine: Improved benefit-risk ratio?Anne C Baakman, Ellen 't Hart, Denis G Kay, et al.
Neuroimage|December 21, 2017
Serotonergic and cholinergic modulation of functional brain connectivity: A comparison between young and older adultsBernadet L Klaassens, Joop M A van Gerven, Erica S Klaassen, et al.
Neuroimage|May 22, 2019
Cholinergic and serotonergic modulation of resting state functional brain connectivity in Alzheimer's diseaseBernadet L Klaassens, Joop M A van Gerven, Erica S Klaassen, et al.
Biology|October 27, 2020
The Effect of a 13-Valent Conjugate Pneumococcal Vaccine on Circulating Antibodies Against Oxidized LDL and Phosphorylcholine in Man, A Randomized Placebo-Controlled Clinical TrialHendrika W Grievink, Pim Gal, Maria Ozsvar Kozma, et al.
Drugs in R&D|June 24, 2021
Safety and Pharmacokinetics of HTL0018318, a Novel M<sub>1</sub> Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly SubjectsCharlotte Bakker, Jasper van der Aart, Geert Labots, et al.
Clinical and Translational Science|April 29, 2023
First-in-human trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of zagociguat (CY6463), a CNS-penetrant soluble guanylyl cyclase stimulatorSebastiaan J W van Kraaij, Pim Gal, Laura G J M Borghans, et al.
Journal of Psychopharmacology (Oxford, England)|December 15, 2015
NS11821, a partial subtype-selective GABAA agonist, elicits selective effects on the central nervous system in randomized controlled trial with healthy subjectsRob G J A Zuiker, Xia Chen, Ole Østerberg, et al.
British Journal of Clinical Pharmacology|July 25, 2023
Randomized placebo-controlled crossover study to assess tolerability and pharmacodynamics of zagociguat, a soluble guanylyl cyclase stimulator, in healthy elderlySebastiaan J W van Kraaij, Laura Borghans, Erica S Klaassen, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|December 30, 2022
Impact of oral administration of single strain <i>Lactococcus lactis</i> spp. <i>cremoris</i> on immune responses to keyhole limpet hemocyanin immunization and gut microbiota: A randomized placebo-controlled trial in healthy volunteersMahdi Saghari, Pim Gal, Hendrika W Grievink, et al.
European Journal of Pain (London, England)|January 1, 2019
The ultraviolet B inflammation model: Postinflammatory hyperpigmentation and validation of a reduced UVB exposure paradigm for inducing hyperalgesia in healthy subjectsPieter S Siebenga, Guido van Amerongen, Erica S Klaassen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
First in human study with a prodrug of galantamine: Improved benefit-risk ratio?Anne C Baakman, Ellen 't Hart, Denis G Kay, et al.
Neuroimage|December 21, 2017
Serotonergic and cholinergic modulation of functional brain connectivity: A comparison between young and older adultsBernadet L Klaassens, Joop M A van Gerven, Erica S Klaassen, et al.
Neuroimage|May 22, 2019
Cholinergic and serotonergic modulation of resting state functional brain connectivity in Alzheimer's diseaseBernadet L Klaassens, Joop M A van Gerven, Erica S Klaassen, et al.
Biology|October 27, 2020
The Effect of a 13-Valent Conjugate Pneumococcal Vaccine on Circulating Antibodies Against Oxidized LDL and Phosphorylcholine in Man, A Randomized Placebo-Controlled Clinical TrialHendrika W Grievink, Pim Gal, Maria Ozsvar Kozma, et al.
Drugs in R&D|June 24, 2021
Safety and Pharmacokinetics of HTL0018318, a Novel M<sub>1</sub> Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly SubjectsCharlotte Bakker, Jasper van der Aart, Geert Labots, et al.
Clinical and Translational Science|April 29, 2023
First-in-human trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of zagociguat (CY6463), a CNS-penetrant soluble guanylyl cyclase stimulatorSebastiaan J W van Kraaij, Pim Gal, Laura G J M Borghans, et al.
Journal of Psychopharmacology (Oxford, England)|December 15, 2015
NS11821, a partial subtype-selective GABAA agonist, elicits selective effects on the central nervous system in randomized controlled trial with healthy subjectsRob G J A Zuiker, Xia Chen, Ole Østerberg, et al.
British Journal of Clinical Pharmacology|July 25, 2023
Randomized placebo-controlled crossover study to assess tolerability and pharmacodynamics of zagociguat, a soluble guanylyl cyclase stimulator, in healthy elderlySebastiaan J W van Kraaij, Laura Borghans, Erica S Klaassen, et al.
Pageof 4